Wednesday, May 31, 2017 9:14:14 AM
GHP owns 6,8% stake in Kitov's equity after TyrNovo deal.
Basically they accepted to be paid in shares. Would you accept to be paid in shares if you didn't know that:
1. they will fund the company operations you sold;
2. Financial safety of the company you will take 6,8% stake;
3. Potential of the company and of its lead drug candidate to increase equity value.
I think that GHP did more DD than everyone else in the planet before accepting (more than Kunhil). Better than any speculative institutional investors.
NT219 is not a simple asset, they didn't sell peanuts. Years of research for a very promising drug (founder is wolf price awarded Alexander Levitzki).
EnricoMania
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM